rrd178814_201904.html

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NdY2BkJvg+HkCsWjD/KL7h5nCFxh14si+rdTnnkUvWHbPAnbFD52pMzcPrKivcQh Qx9ZCIAwcipe8gg9RHq4eQ== 0001181431-08-020311.txt : 20080320 0001181431-08-020311.hdr.sgml : 20080320 20080320132144 ACCESSION NUMBER: 0001181431-08-020311 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080311 FILED AS OF DATE: 20080320 DATE AS OF CHANGE: 20080320 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 BUSINESS PHONE: 805-447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE STREET 2: MAIL STOP 27-3-C CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEIER DAVID W CENTRAL INDEX KEY: 0001187054 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 08701536 BUSINESS ADDRESS: BUSINESS PHONE: 6506241000 MAIL ADDRESS: STREET 1: C/O VAXGEN INC STREET 2: 1000 MARINA BLVD #200 CITY: BRISBANE STATE: CA ZIP: 94005 3 1 rrd200266.xml FORM 3 X0202 3 2008-03-11 0 0000318154 AMGEN INC AMGN 0001187054 BEIER DAVID W ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 0 1 0 0 SVP Global Govt & Corp Affairs Common Stock 25000 D Common Stock 15824 D ISO (Right to Buy) 59.48 2008-03-15 2011-03-15 Common Stock 3362 D ISO (Right to Buy) 62.15 2004-12-17 2010-12-17 Common Stock 6436 D ISO (Right to Buy) 62.55 2011-04-26 2014-04-26 Common Stock 1598 D ISO (Right to Buy) 71.88 2010-04-03 2013-04-03 Common Stock 1391 D NQSO (Right to Buy) 58.61 2006-03-15 2012-03-15 Common Stock 17500 D NQSO (Right to Buy) 59.48 2005-03-15 2011-03-15 Common Stock 6336 D NQSO (Right to Buy) 62.15 2004-12-17 2010-12-17 Common Stock 40732 D NQSO (Right to Buy) 62.55 2008-04-26 2014-04-26 Common Stock 23402 D NQSO (Right to Buy) 71.88 2007-04-03 2013-04-03 Common Stock 23609 D The Restricted Stock Units (RSUs) were granted under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs will fully vest on July 31, 2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. This option is exercisable in two equal annual installments of 1,681 shares each commencing March 15, 2008. This option is exercisable in four equal annual installments of 4,375 shares each commencing March 15, 2006. This option is exercisable in five annual installments as follows: 3,168 shares on March 15, 2005; 3,168 shares on March 15, 2006; 3,168 shares on March 15, 2007; 1,487 shares on March 15, 2008; and 1,487 shares on March 15, 2009. This option was exercisable in four equal annual installments commencing December 17, 2004 and is now fully vested. This option is exercisable in four annual installments as follows: 6,250 shares on April 26, 2008; 6,250 shares on April 26, 2009; 6,250 shares on April 26, 2010; and 4,652 shares on April 26, 2011. This option is exercisable in four annual installments as follows: 6,250 shares on April 3, 2007; 6,250 shares on April 3, 2008; 6,250 shares on April 3, 2009; and 4,859 shares on April 3, 2010. /s/ David W. Beier 2008-03-18 EX-24.1 2 rrd178814_201904.htm POWER OF ATTORNEY rrd178814_201904.html

                                                                    Exhibit 24.1
                               POWER OF ATTORNEY

        Know all men by these presents, that the undersigned hereby constitutes
and appoints each of N. Cris Prince, Andrea A. Robinson and Mark A. Schlossberg,
signing singly, the undersigned's true and lawful attorney-in-fact to execute
for and on behalf of the undersigned Forms 3, 4 and 5 in accordance with Section
16(a) of the Securities Exchange Act of 1934, as amended, and the rules
thereunder, as may be required as a result of the undersigned's position as an
officer and/or director of Amgen Inc. (the "Company").

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to execute such Forms 3, 4 and 5 as fully to all intents and
purposes as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney and
the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 17th day of March, 2008.

                                        /s/ David W. Beier
                                        ---------------------------------------
                                        Name:  David W. Beier

-----END PRIVACY-ENHANCED MESSAGE-----